Company

MaveriX Oncology, Inc.

MaveriX Oncology develops targeted therapeutics for solid tumors from Palo Alto, US.

About

Founded in 2014 and headquartered in Palo Alto, US, MaveriX Oncology, Inc. develops targeted cancer therapeutics for solid tumors using Conditionally Activated Small Molecule Therapeutics that act on both cancer cells and the tumor immune microenvironment. Its products are aimed at healthcare providers in North America and Europe. The company completed one funding round, a USD 6.5 mn Series A led by PPF Group on October 14, 2019. CEO Steven Everett leads the company.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in